Off-label uses of TNF-a inhibitors and IL-12/23 inhibitors in dermatology.

Hong, Julie J; Hadeler, Edward K; Mosca, Megan L; Brownstone, Nicholas D; Bhutani, Tina; Liao, Wilson J

Hong, Julie J; Hadeler, Edward K; Mosca, Megan L; Brownstone, Nicholas D; Bhutani, Tina; Liao, Wilson J.

Affiliation

Hong JJ; University of California San Francisco, Department of Dermatology, Psoriasis and Skin Treatment Center. Julie.hong2@ucsf.edu.

Dermatol Online J ; 27(11)2021 Nov 15.

Article in En | MEDLINE | ID: mdl-35130397

Subject(s)

Dermatology; Interleukin Inhibitors/therapeutic use; Off-Label Use; Tumor Necrosis Factor Inhibitors/therapeutic use; Adalimumab/therapeutic use; Alopecia Areata/drug therapy; Antibodies, Monoclonal/therapeutic use; Certolizumab Pegol/therapeutic use; Dermatitis, Atopic/drug therapy; Etanercept/therapeutic use; Granuloma Annulare/drug therapy; Hidradenitis Suppurativa/drug therapy; Humans; Infliximab/therapeutic use; Lupus Erythematosus, Systemic/drug therapy; Pemphigus/drug therapy; Pyoderma Gangrenosum/drug therapy; Sarcoidosis/drug therapy; Stevens-Johnson Syndrome/drug therapy; Ustekinumab/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dermatology / Off-Label Use / Tumor Necrosis Factor Inhibitors / Interleukin Inhibitors Limits: Humans Language: En Journal: Dermatol Online J Journal subject: DERMATOLOGIA Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google